Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.
Saved in:
| Title: | Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. |
|---|---|
| Authors: | Hurwitz, Selwyn J.1 (AUTHOR) shurwit@emory.edu, De, Ramyani1 (AUTHOR) ramyani.de@emory.edu, LeCher, Julia C.1 (AUTHOR) julia.christine.lecher@emory.edu, Downs-Bowen, Jessica A.1 (AUTHOR) jadowns@emory.edu, Goh, Shu Ling1 (AUTHOR) shuling.9191@gmail.com, Zandi, Keivan1 (AUTHOR) keivanzandi@yahoo.com, McBrayer, Tamara1 (AUTHOR) tamara.mcbrayer@emory.edu, Amblard, Franck1 (AUTHOR) famblar@emory.edu, Patel, Dharmeshkumar1 (AUTHOR) dharmeshkumar.j.patel@emory.edu, Kohler, James J.1 (AUTHOR) jkohler35@hotmail.com, Bhasin, Manoj2 (AUTHOR) manoj.bhasin@emory.edu, Dobosh, Brian S.2 (AUTHOR) brian.seth.dobosh@emory.edu, Sukhatme, Vikas3 (AUTHOR) vsukhatme@emory.edu, Tirouvanziam, Rabindra M.2 (AUTHOR) tirouvanziam@emory.edu, Schinazi, Raymond F.1 (AUTHOR) rschina@emory.edu |
| Source: | Viruses (1999-4915). Apr2024, Vol. 16 Issue 4, p651. 26p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
